Prospects for Safer Psychopharmacologic Treatment of Affective Disorders in the Elderly
With our present pharmaceutical and somatic modalities of intervention a very high percentage of elderly depressives may be effectively treated. Although a wide variety of side effects have been associated with the use of antidepressants such as TCAs, these may be minimized by (1) an understanding of the drug’s affinities for specific receptors; (2) a knowledge of the physiologic changes associated with normal and pathological aging which effect the pharmacokinetics of the TCA; (3) appropriate sampling of plasma levels; and (4) avoiding drug-drug interactions.
The future holds great promise for the development of new antidepressants that will be more specific and have a fewer side effects. As the specificity of antidepressants is increased, the greater will be the opportunities for understanding the biological underpinnings of depression in the elderly who so often challenge our diagnostic and clinical abilities.
KeywordsDepression Lithium Histamine Indomethacin Haloperidol
Unable to display preview. Download preview PDF.
- Blazer, D.: Depression in Late Life, 1st ed., Ch. 2. St. Louis: C.V. Mosby, 1982.Google Scholar
- Cole, J.: New antidepressant drugs. McLean Hospital Journal 8, 62–77 (1983a).Google Scholar
- Cole, J.O., Branconnier, R., Solomon, M., and Dessain, E.: Tricyclic use in the cognitively impaired elderly. J. Clin. Psychiatry 44, 14-19 (1983 b).Google Scholar
- Hollister, L.E.: General principles of psychotherapeutic drug use in the aged. In Crook, T., and Cohen, G. (Eds.), Physician’s Handbook on Psychotherapeutic Drug Use in the Aged, 1st ed., Ch. 1, Mark Powley Associates, Inc. New Canaan, Conn.: 1981.Google Scholar
- Young, R.C., Manley, M.W., Shamoian, C.A., and Kutt, H.: Therapeutic Response to Nortriptyline in the Elderly. Proceedings of American Psychiatric Association, 135th Annual Meeting, Toronto, 1982, p. 210. Washington, D.C.: APA, 1982.Google Scholar
- Young, R.C., Alexopoulos, G.S., Shamoian, C.A., et al.: Heart failure and plasma 10-hydroxynortriptyline. Am. J. Psychiatry 141, 3 (1984b).Google Scholar